Cargando…

A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant brain tumor in adulthood. Despite multimodality treatments, including maximal safe resection followed by irradiation and chemotherapy, the median overall survival times range from 14 to 16 months. However, a small subset of GBM pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferguson, Sherise D, Hodges, Tiffany R, Majd, Nazanin K, Alfaro-Munoz, Kristin, Al-Holou, Wajd N, Suki, Dima, de Groot, John F, Fuller, Gregory N, Xue, Lee, Li, Miao, Jacobs, Carmen, Rao, Ganesh, Colen, Rivka R, Xiu, Joanne, Verhaak, Roel, Spetzler, David, Khasraw, Mustafa, Sawaya, Raymond, Long, James P, Heimberger, Amy B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780842/ https://www.ncbi.nlm.nih.gov/pubmed/33426529 http://dx.doi.org/10.1093/noajnl/vdaa146

Ejemplares similares

Ependymomas overexpress chemoresistance and DNA repair-related proteins
por: Ferguson, Sherise D., et al.
Publicado: (2017)

A Time-Tested Information System in Neurosurgical Oncology
por: Suki, Dima, et al.
Publicado: (2018)

The natural history of EGFR and EGFRvIII in glioblastoma patients
por: Heimberger, Amy B, et al.
Publicado: (2005)

Innate immune functions of microglia isolated from human glioma patients
por: Hussain, S Farzana, et al.
Publicado: (2006)

Serum microRNA profiling in patients with glioblastoma: a survival analysis
por: Zhao, Hua, et al.
Publicado: (2017)

Profiles of brain metastases: Prioritization of therapeutic targets
por: Ferguson, Sherise D., et al.
Publicado: (2018)

Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
por: Ferguson, Sherise D, et al.
Publicado: (2018)

Rethinking medulloblastoma from a targeted therapeutics perspective
por: Hashimoto, Yuuri, et al.
Publicado: (2018)

Stem cells for the treatment of glioblastoma: a 20-year perspective
por: Calinescu, Anda-Alexandra, et al.
Publicado: (2021)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
por: Najem, Hinda, et al.
Publicado: (2021)

SURG-12. A COMPARISON BETWEEN PROGNOSTIC SCORES OF BREAST CANCER BRAIN METASTASES APPLIED TO A NEUROSURGICAL POPULATION
por: Bastos, Dhiego, et al.
Publicado: (2019)

H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy
por: Pun, Matthew, et al.
Publicado: (2020)

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
por: de Groot, John, et al.
Publicado: (2022)

MRI-Guided Stereotactic Biopsy of Murine GBM for Spatiotemporal Molecular Genomic Assessment
por: Galbán, Stefanie, et al.
Publicado: (2017)

2245. Primary Central Nervous System Lymphoma in Patients with HIV and Non-HIV: Should We Treat Them Differently?
por: Dandachi, Dima, et al.
Publicado: (2018)

MLTI-10. ESTABLISHMENT OF A MULTIDISCIPLINARY BRAIN METASTASIS CLINIC TO FACILITATE PATIENT-CENTERED CARE AND COORDINATED RESEARCH
por: Li, Jing, et al.
Publicado: (2019)

Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
por: Ott, Martina, et al.
Publicado: (2020)

Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
por: Najem, Hinda, et al.
Publicado: (2022)

Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation
por: Khan, Bilal, et al.
Publicado: (2020)

Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome
por: Chong, Insun, et al.
Publicado: (2019)

Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases
por: Zhu, Viola W, et al.
Publicado: (2020)

Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma
por: Al-Holou, Wajd N., et al.
Publicado: (2023)

GBM-associated mutations and altered protein expression are more common in young patients
por: Ferguson, Sherise D., et al.
Publicado: (2016)

The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival
por: Lee, Ian, et al.
Publicado: (2012)

TIPS-15 NEUROCOGNITIVE FUNCTION AND NEUROCOGNITIVE CONCERNS IN AN ONGOING PHASE III TRIAL OF PRE-OPERATIVE SRS VERSUS POST-OPERATIVE SRS FOR BRAIN METASTASES
por: Wefel, Jeffrey, et al.
Publicado: (2023)

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
por: Gregory, Timothy A, et al.
Publicado: (2023)

The role of resting-state functional MRI for clinical preoperative language mapping
por: Kumar, Vinodh A., et al.
Publicado: (2020)

Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
por: Comba, Andrea, et al.
Publicado: (2021)

Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
por: Khan, Sabbir, et al.
Publicado: (2020)

The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection
por: Muscat, Andrea M., et al.
Publicado: (2017)

Corrigendum to “Automated Feature Extraction in Brain Tumor by Magnetic Resonance Imaging Using Gaussian Mixture Models”
por: Chaddad, Ahmad, et al.
Publicado: (2017)

yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients
por: Humphries, William, et al.
Publicado: (2009)

Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity
por: Hassan, Islam, et al.
Publicado: (2016)

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes
por: Zhao, Hua, et al.
Publicado: (2016)

DDRE-19. PHASE 0/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM
por: Umemura, Yoshie, et al.
Publicado: (2021)

Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma
por: Kassab, Cynthia, et al.
Publicado: (2019)

Nomograms of Iranian fetal middle cerebral artery Doppler waveforms and uniformity of their pattern with other populations' nomograms
por: Tarzamni, Mohammad Kazem, et al.
Publicado: (2008)

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
por: Majd, Nazanin K, et al.
Publicado: (2021)

Preclinical Models of Low-Grade Gliomas
por: Dasgupta, Pushan, et al.
Publicado: (2023)

Extraskeletal Myxoid Chondrosarcoma Presenting as an Intradural Spinal Mass: Report of a Rare Clinical Presentation With an Emphasis on Differential Diagnostic Considerations
por: Rao, Priya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1db9o60rti9u1naraqiogv4h9d